Global Microbiome Therapeutics and Diagnostics Market Insights, Forecast to 2028
SKU ID : QYR-20595317 | Publishing Date : 16-Mar-2022 | No. of pages : 88
Detailed TOC of Global Microbiome Therapeutics and Diagnostics Market Insights, Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 FMT
1.2.3 Microbiome Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Stomach
1.3.3 Respiratory Tract
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Therapeutics and Diagnostics Market Perspective (2017-2028)
2.2 Microbiome Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Microbiome Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Microbiome Therapeutics and Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Microbiome Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Microbiome Therapeutics and Diagnostics Market Dynamics
2.3.1 Microbiome Therapeutics and Diagnostics Industry Trends
2.3.2 Microbiome Therapeutics and Diagnostics Market Drivers
2.3.3 Microbiome Therapeutics and Diagnostics Market Challenges
2.3.4 Microbiome Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Microbiome Therapeutics and Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Microbiome Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapeutics and Diagnostics Revenue
3.4 Global Microbiome Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Microbiome Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics and Diagnostics Revenue in 2021
3.5 Microbiome Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Microbiome Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Microbiome Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Microbiome Therapeutics and Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028)
5 Microbiome Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Microbiome Therapeutics and Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Microbiome Therapeutics and Diagnostics Market Size (2017-2028)
6.2 North America Microbiome Therapeutics and Diagnostics Market Size by Type
6.2.1 North America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028)
6.3 North America Microbiome Therapeutics and Diagnostics Market Size by Application
6.3.1 North America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028)
6.4 North America Microbiome Therapeutics and Diagnostics Market Size by Country
6.4.1 North America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Microbiome Therapeutics and Diagnostics Market Size (2017-2028)
7.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Type
7.2.1 Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028)
7.3 Europe Microbiome Therapeutics and Diagnostics Market Size by Application
7.3.1 Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028)
7.4 Europe Microbiome Therapeutics and Diagnostics Market Size by Country
7.4.1 Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Type
8.2.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Application
8.3.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region
8.4.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Microbiome Therapeutics and Diagnostics Market Size (2017-2028)
9.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Type
9.2.1 Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Microbiome Therapeutics and Diagnostics Market Size by Application
9.3.1 Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country
9.4.1 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Type
10.2.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Application
10.3.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country
10.4.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 4D Pharma
11.1.1 4D Pharma Company Details
11.1.2 4D Pharma Business Overview
11.1.3 4D Pharma Microbiome Therapeutics and Diagnostics Introduction
11.1.4 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
11.1.5 4D Pharma Recent Developments
11.2 Capsugel
11.2.1 Capsugel Company Details
11.2.2 Capsugel Business Overview
11.2.3 Capsugel Microbiome Therapeutics and Diagnostics Introduction
11.2.4 Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
11.2.5 Capsugel Recent Developments
11.3 Gusto Global
11.3.1 Gusto Global Company Details
11.3.2 Gusto Global Business Overview
11.3.3 Gusto Global Microbiome Therapeutics and Diagnostics Introduction
11.3.4 Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
11.3.5 Gusto Global Recent Developments
11.4 MatriSys Bioscience
11.4.1 MatriSys Bioscience Company Details
11.4.2 MatriSys Bioscience Business Overview
11.4.3 MatriSys Bioscience Microbiome Therapeutics and Diagnostics Introduction
11.4.4 MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
11.4.5 MatriSys Bioscience Recent Developments
11.5 Pierre Fabre
11.5.1 Pierre Fabre Company Details
11.5.2 Pierre Fabre Business Overview
11.5.3 Pierre Fabre Microbiome Therapeutics and Diagnostics Introduction
11.5.4 Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
11.5.5 Pierre Fabre Recent Developments
11.6 Sunstone Capital
11.6.1 Sunstone Capital Company Details
11.6.2 Sunstone Capital Business Overview
11.6.3 Sunstone Capital Microbiome Therapeutics and Diagnostics Introduction
11.6.4 Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
11.6.5 Sunstone Capital Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global Microbiome Therapeutics and Diagnostics Market Insights, Forecast to 2028
List of TablesTable 1. Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of FMT
Table 3. Key Players of Microbiome Drugs
Table 4. Key Players of Others
Table 5. Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Microbiome Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Microbiome Therapeutics and Diagnostics Market Share by Region (2017-2022)
Table 9. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Microbiome Therapeutics and Diagnostics Market Share by Region (2023-2028)
Table 11. Microbiome Therapeutics and Diagnostics Market Trends
Table 12. Microbiome Therapeutics and Diagnostics Market Drivers
Table 13. Microbiome Therapeutics and Diagnostics Market Challenges
Table 14. Microbiome Therapeutics and Diagnostics Market Restraints
Table 15. Global Microbiome Therapeutics and Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Microbiome Therapeutics and Diagnostics Revenue Share by Players (2017-2022)
Table 17. Global Top Microbiome Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics and Diagnostics as of 2021)
Table 18. Ranking of Global Top Microbiome Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Microbiome Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Microbiome Therapeutics and Diagnostics Product Solution and Service
Table 22. Date of Enter into Microbiome Therapeutics and Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Type (2017-2022)
Table 26. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Type (2023-2028)
Table 28. Global Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Microbiome Therapeutics and Diagnostics Revenue Share by Application (2017-2022)
Table 30. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Microbiome Therapeutics and Diagnostics Revenue Share by Application (2023-2028)
Table 32. North America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 62. 4D Pharma Company Details
Table 63. 4D Pharma Business Overview
Table 64. 4D Pharma Microbiome Therapeutics and Diagnostics Product
Table 65. 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
Table 66. 4D Pharma Recent Developments
Table 67. Capsugel Company Details
Table 68. Capsugel Business Overview
Table 69. Capsugel Microbiome Therapeutics and Diagnostics Product
Table 70. Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
Table 71. Capsugel Recent Developments
Table 72. Gusto Global Company Details
Table 73. Gusto Global Business Overview
Table 74. Gusto Global Microbiome Therapeutics and Diagnostics Product
Table 75. Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
Table 76. Gusto Global Recent Developments
Table 77. MatriSys Bioscience Company Details
Table 78. MatriSys Bioscience Business Overview
Table 79. MatriSys Bioscience Microbiome Therapeutics and Diagnostics Product
Table 80. MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
Table 81. MatriSys Bioscience Recent Developments
Table 82. Pierre Fabre Company Details
Table 83. Pierre Fabre Business Overview
Table 84. Pierre Fabre Microbiome Therapeutics and Diagnostics Product
Table 85. Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
Table 86. Pierre Fabre Recent Developments
Table 87. Sunstone Capital Company Details
Table 88. Sunstone Capital Business Overview
Table 89. Sunstone Capital Microbiome Therapeutics and Diagnostics Product
Table 90. Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
Table 91. Sunstone Capital Recent Developments
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Therapeutics and Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. FMT Features
Figure 3. Microbiome Drugs Features
Figure 4. Others Features
Figure 5. Global Microbiome Therapeutics and Diagnostics Market Share by Application: 2021 VS 2028
Figure 6. Stomach Case Studies
Figure 7. Respiratory Tract Case Studies
Figure 8. Other Case Studies
Figure 9. Microbiome Therapeutics and Diagnostics Report Years Considered
Figure 10. Global Microbiome Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Microbiome Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Microbiome Therapeutics and Diagnostics Market Share by Region: 2021 VS 2028
Figure 13. Global Microbiome Therapeutics and Diagnostics Market Share by Players in 2021
Figure 14. Global Top Microbiome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics and Diagnostics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Microbiome Therapeutics and Diagnostics Revenue in 2021
Figure 16. North America Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
Figure 18. North America Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
Figure 19. North America Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
Figure 20. United States Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
Figure 24. Europe Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
Figure 25. Europe Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
Figure 26. Germany Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size Share by Region (2017-2028)
Figure 36. China Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
Figure 46. Mexico Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
Figure 52. Turkey Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
Figure 56. Capsugel Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
Figure 57. Gusto Global Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
Figure 58. MatriSys Bioscience Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
Figure 59. Pierre Fabre Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
Figure 60. Sunstone Capital Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Keyplayers in Global Microbiome Therapeutics and Diagnostics Market Insights, Forecast to 2028
4D PharmaCapsugel
Gusto Global
MatriSys Bioscience
Pierre Fabre
Sunstone Capital